S. Praprotnik

发表

EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome

P. Ravaud, X. Mariette, E. Theander, 2011, Annals of the rheumatic diseases.

Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium.

A. Vissink, D. Isenberg, J. Sánchez-Guerrero, 2021, Clinical and experimental rheumatology.

How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).

D. Isenberg, J. Sánchez-Guerrero, X. Mariette, 2018, Clinical and experimental rheumatology.

Clinical–pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis

L. Lusa, M. Tomšič, S. Praprotnik, 2016, The Pharmacogenomics Journal.

Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis: a comprehensive overview of methodology pitfalls and benefits

S. Čučnik, B. Božič, M. Tomšič, 2017, Immunologic research.

Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis

J. Žibert, S. Pirkmajer, M. Thevis, 2016, Scandinavian journal of rheumatology.

Leflunomide-associated tuberculosis?

M. Tomšič, S. Praprotnik, A. Hočevar, 2006, Rheumatology.

Neutralizing effects of anti-infliximab antibodies on synergistically-stimulated human coronary artery endothelial cells.

S. Čučnik, S. Praprotnik, P. Žigon, 2019, Atherosclerosis.

Chapter 14 – Paraneoplastic Arthritis

M. Tomšič, S. Praprotnik, 2000 .

Sequential synovial fluid sampling suggests plasma and synovial fluid IL-6 vary independently in rheumatoid arthritis

D., M., Á., 2006 .

Features associated with epilepsy in the antiphospholipid syndrome.

J. Piette, J. Chapman, G. Hughes, 2004, The Journal of rheumatology.

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

E. Nasonov, M. Tomšič, J. Skoupá, 2011, Medical science monitor : international medical journal of experimental and clinical research.

A concise review of significantly modified serological biomarkers in giant cell arteritis, as detected by different methods.

G. Thallinger, S. Čučnik, M. Tomšič, 2017, Autoimmunity reviews.

Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine.

Y. Shoenfeld, S. Praprotnik, D. Kanduc, 2016, Seminars in hematology.

Microthrombotic/Microangiopathic Manifestations of the Antiphospholipid Syndrome

S. Praprotnik, B. Rozman, T. Avčin, 2009, Clinical reviews in allergy & immunology.

Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.

D. Isenberg, J. Sánchez-Guerrero, X. Mariette, 2019, Rheumatology.

Autoantibodies to Cardiolipin and Beta-2-Glycoprotein-I in Coronary Artery Disease Patients with and without Hypertension

A. Tenenbaum, E. Fisman, M. Motro, 2002, Cardiology.

Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications.

Y. Shoenfeld, S. Praprotnik, A. Eldor, 2002, Arthritis and rheumatism.

Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels.

Y. Shoenfeld, M. Blank, V. Barak, 1999, Arthritis and rheumatism.

Anti-Endothelial Cell Antibodies (AECA) in Systemic Sclerosis - Increased Sensitivity using Different Endothelial Cell Substrates and Association with Other Autoantibodies

Y. Shoenfeld, B. Gilburd, P. Youinou, 2001, Autoimmunity.

Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis.

Y. Shoenfeld, S. Praprotnik, B. Rozman, 2000, Wiener klinische Wochenschrift.

FRI0249 IGAV Score – A Feasible Predictor of IGA Vasculitis Severity

M. Tomšič, S. Praprotnik, A. Hočevar, 2015 .

New issues in tuberculosis.

M. Tomšič, S. Praprotnik, B. Rozman, 2005, Annals of the rheumatic diseases.

Parasympathetic nervous system dysfunction in primary Sjögren’s syndrome

T. Kveder, M. Tomšič, S. Praprotnik, 2003, Annals of the rheumatic diseases.

Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjögren's syndrome: a prospective study.

T. Kveder, B. Božič, S. Praprotnik, 1999, Clinical and experimental rheumatology.

A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature

M. Tomšič, S. Praprotnik, K. Perdan-Pirkmajer, 2010, Clinical Rheumatology.

Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases.

A. Vissink, X. Mariette, B. Kostov, 2020, Clinical and experimental rheumatology.

The immunogenicity of seasonal and pandemic influenza vaccination in autoimmune inflammatory rheumatic patients—a 6-month follow-up prospective study

S. Čučnik, M. Tomšič, S. Praprotnik, 2019, Clinical Rheumatology.

Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease

G. Thallinger, S. Čučnik, T. Kveder, 2012, Lupus.

Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.

J. Sánchez-Guerrero, X. Mariette, S. Bombardieri, 2019, Clinical and experimental rheumatology.

Prognostic value of contrast enhanced Gd-DTPA MRI for development of bone erosive changes in rheumatoid arthritis.

V. Jevtič, F. Demsar, M. Tomšič, 1996, British journal of rheumatology.

Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: a review of the literature

C. Lau, Der-Yuan Chen, L. Llamado, 2017, International journal of rheumatic diseases.

Retention of the second-line biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis failing one tumor necrosis factor alpha inhibitor: data from the BioRx.si registry

M. Tomšič, S. Praprotnik, A. Hočevar, 2015, Clinical Rheumatology.

Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements

S. Čučnik, M. Tomšič, S. Praprotnik, 2018, Clinical Rheumatology.

Leflunomide and hypertension

M. Tomšič, P. Dolenc, S. Praprotnik, 2002, Annals of the rheumatic diseases.

Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells.

Y. Shoenfeld, M. Blank, B. Weksler, 2002, International immunology.

AB0334 Methotrexate Reduces Hba1c in Non-Diabetic Patients with Newly Diagnosed Rheumatoid Arthritis or Psoriatic Arthritis

S. Pirkmajer, M. Tomšič, S. Praprotnik, 2014 .

Prevalence and Clinical Correlations of Antibodies Against Six β2-Glycoprotein-I-Related Peptides in the Antiphospholipid Syndrome

J. Piette, G. Hughes, Y. Shoenfeld, 2003, Journal of Clinical Immunology.

Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 children.

A. Vissink, D. Isenberg, X. Mariette, 2021, Rheumatology.

Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.

A. Vissink, D. Isenberg, J. Gottenberg, 2020, Clinical and experimental rheumatology.

Comment on: Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?

M. Tomšič, S. Praprotnik, A. Hočevar, 2019, Rheumatology.

Concerns about the prevalence of primary Sjögren's syndrome: comment on the article by Theander et al.

M. Tomšič, S. Praprotnik, Ž. Rotar, 2005, Arthritis and rheumatism.

The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients.

Y. Shoenfeld, M. Tomšič, S. Praprotnik, 2008, Journal of autoimmunity.

Osteoporosis, vitamin D deficiency, and supplementation in juvenile systemic lupus erythematosus: comment on the article by Compeyrot-Lacassagne et al.

M. Tomšič, S. Praprotnik, 2007, Arthritis and rheumatism.

Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells.

Y. Shoenfeld, Y. Levy, B. Weksler, 2001, International immunology.

Routinely utilized in-house assays for infliximab, adalimumab and their anti-drug antibody levels

S. Čučnik, S. Praprotnik, P. Žigon, 2018, Immunologic research.

NLRP3 and CARD8 Polymorphisms Influence Higher Disease Activity in Rheumatoid Arthritis

M. Tomšič, S. Praprotnik, V. Dolžan, 2016, Journal of medical biochemistry.

The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients

J. Piette, Y. Shoenfeld, G. Espinosa, 2018, Rheumatology.

Digital ulcers as the first manifestation of carpal tunnel syndrome

M. Tomšič, S. Praprotnik, K. Perdan-Pirkmajer, 2011, Rheumatology International.

Comment on: High-risk pregnancy and the rheumatologist.

M. Tomšič, S. Praprotnik, Ž. Rotar, 2015, Rheumatology.

Is Sjögren's syndrome involved in the formation of localised nodular amyloidosis?

M. Tomšič, S. Praprotnik, A. Vizjak, 2001, Clinical and experimental rheumatology.

Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells

S. Čučnik, M. Tomšič, S. Praprotnik, 2018, PloS one.

Monitoring ankylosing spondylitis therapy by dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging

I. Serša, V. Jevtič, M. Tomšič, 2008, Skeletal Radiology.

Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium

D. Isenberg, J. Sánchez-Guerrero, X. Mariette, 2016, Annals of the rheumatic diseases.

Letter to the Editor

S. Praprotnik, J. Preželj, 1995 .

Silicone implants and lymphoma: The role of inflammation.

M. Ehrenfeld, Y. Shoenfeld, C. Selmi, 2015, Journal of autoimmunity.

Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry

Y. Shoenfeld, S. Praprotnik, S. Dahan, 2017, Immunologic research.

International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis

G. Thallinger, M. Aringer, J. Vencovský, 2012, Arthritis Research & Therapy.

AB0581 The Estimated Annual Incidence Rate of Polyarteritis Nodosa in Slovenia

M. Tomšič, S. Praprotnik, A. Hočevar, 2014 .

Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesis.

S. Praprotnik, A. Vizjak, J. Jeruc, 2000, Wiener klinische Wochenschrift.

Clinical contrasts with the American College of Rheumatology/European League Against Rheumatism provisional definitions of remission in rheumatoid arthritis for clinical trials: Comment on the article by Felson et al.

M. Tomšič, S. Praprotnik, Ž. Rotar, 2011, Arthritis and rheumatism.

Routinely utilized in-house assays for infliximab, adalimumab and their anti-drug antibody levels

S. Čučnik, S. Praprotnik, P. Žigon, 2018, Immunologic Research.

Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS)

Y. Shoenfeld, A. Doria, N. Agmon-Levin, 2013, Lupus.

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

G. Baron, P. Ravaud, X. Mariette, 2014, Annals of the rheumatic diseases.

Functional Heterogeneity of Pathogenic Anti-Endothelial Cell Antibodies

Y. Shoenfeld, P. Meroni, S. Praprotnik, 2001 .

Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis: a comprehensive overview of methodology pitfalls and benefits

S. Čučnik, B. Božič, M. Tomšič, 2016, Immunologic Research.

Azathioprine induced hepatic veno-occlusive disease in systemic lupus erythematosus.

M. Tomšič, S. Praprotnik, A. Hočevar, 2005, Lupus.

Letter to the Editor

M. Tomšič, S. Praprotnik, A. Hočevar, 2005 .

THU0628 IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES. BIG DATA ANALYSIS OF 13,051 CASES (IMMUNOCANCER INTERNATIONAL REGISTRY)

M. Suarez‐Almazor, X. Mariette, J. Gottenberg, 2019, Poster Presentations.

Prolactin’s role in the pathogenesis of the antiphospholipid syndrome

Y. Shoenfeld, N. Agmon-Levin, R. Cervera, 2010, Lupus.

The Role of Statins on the Outcomes on the Cholesterol Embolism Syndrome with Secondary Vasculitis-A Case Report and Review of the Literature

M. Tomšič, S. Praprotnik, A. Hočevar, 2017 .

Autoantibodies to oxidized low-density lipoprotein in coronary artery disease.

A. Tenenbaum, E. Fisman, M. Motro, 2001, American journal of hypertension.

Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients

G. Thallinger, S. Čučnik, M. Tomšič, 2018, Clinical Rheumatology.

Coronary Artery Disease but Not Coronary Calcification Is Associated with Elevated Levels of Cardiolipin, Beta-2-Glycoprotein-I, and Oxidized LDL Antibodies

A. Tenenbaum, E. Fisman, M. Motro, 2001, Cardiology.

Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain.

A. Tenenbaum, M. Motro, Y. Shoenfeld, 2000, The American journal of cardiology.

FRI0419 Big Data Sjogren Project (Eular-SS Task Force International Network): Systemic Involvement at Diagnosis Evaluated by the Essdai in 3314 Patients with Primary Sjögren Syndrome

D. Isenberg, J. Sánchez-Guerrero, X. Mariette, 2015 .

Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis

S. Praprotnik, B. Rozman, D. Logar, 2009, Annals of the rheumatic diseases.

A decrease in antiphospholipid antibodies before a thrombotic event

B. Božič, S. Praprotnik, 1996, Clinical Rheumatology.

Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study

S. Srinivasan, K. Pavelka, A. Loft, 2012, Annals of the rheumatic diseases.

Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models

Vita Dolžan, Matija Tomšič, M. Tomšič, 2018, Front. Pharmacol..

The persistence of golimumab compared to other tumour necrosis factor-α inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic

M. Tomšič, S. Praprotnik, Ž. Rotar, 2018, Clinical Rheumatology.

Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry

Y. Shoenfeld, S. Praprotnik, S. Dahan, 2016, Immunologic Research.

Clinically important neutralizing anti-drug antibodies detected with an in-house competitive ELISA

S. Čučnik, S. Praprotnik, P. Žigon, 2018, Clinical Rheumatology.

Is malignant infiltration necessary for development of leukemic arthritis? Comment on the article by Rudwaleit et al.

M. Tomšič, S. Praprotnik, 1999, Arthritis and rheumatism.

THU0649 PHENOTYPIC CLUSTERS OF RHEUMATIC/SYSTEMIC IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES (IMMUNOCANCER INTERNATIONAL REGISTRY)

M. Suarez‐Almazor, X. Mariette, J. Gottenberg, 2019, Poster Presentations.

P071 Autoantibodies against serum amyloid a reduce il-6 release from peripheral blood mononuclear cells

S. Čučnik, M. Tomšič, S. Praprotnik, 2018 .

SAT0683 A north-south worldwide gradient in systemic activity of primary sjÖgren syndrome: increased severe disease in patients from southern countries

D. Isenberg, J. Gottenberg, V. Devauchelle-Pensec, 2018, Saturday, 16 JUNE 2018.

Characterization and outcomes of 414 patients with primary SS who developed hematological malignancies.

A. Vissink, D. Isenberg, X. Mariette, 2022, Rheumatology.

Contrast enhanced Gd-DTPA magnetic resonance imaging in the evaluation of rheumatoid arthritis during a clinical trial with DMARDs. A prospective two-year follow-up study on hand joints in 31 patients.

V. Jevtič, F. Demsar, S. Praprotnik, 1997, Clinical and experimental rheumatology.

Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study

A. Vissink, X. Mariette, S. Bombardieri, 2023, eClinicalMedicine.

Comment on: Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.

M. Tomšič, S. Praprotnik, 2020, Clinical and experimental rheumatology.

FRI0303 Validation of eular primary sjögren’s syndrome disease activity and patient indexes

P. Ravaud, X. Mariette, E. Theander, 2012 .

Survivin polymorphism is associated with disease activity in rheumatoid arthritis patients.

S. Čučnik, M. Tomšič, S. Praprotnik, 2016, Pharmacogenomics.

Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry

Y. Shoenfeld, S. Praprotnik, S. Dahan, 2016, Immunologic Research.

Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome.

B. Armağan, V. Fernandes Moça Trevisani, G. Nordmark, 2023, Clinical and experimental rheumatology.

THU0268 Visual Complications in Giant Cell Arteritis – Beyond Inflammation

M. Tomšič, S. Praprotnik, A. Hočevar, 2015 .